-
Palovarotene in fibrodysplasia ossificans progressiva: review and perspective
Verheij, V. A., Diecidue, R. J., Botman, E., Harrington, J. D., Haga, N., Hidalgo-Bravo, A., Delai, P. L. R., Madhuri, V., Al Mukaddam, M., Zhang, K., Cho, T.-J., Morhart, R., Keen, R., de Cunto, C. L., Friedman, C. S., Grunwald, Z., Zasloff, M., Netelenbos, J. C., Hsiao, E. & Kaplan, F. S. & 3 others, , 2025, In: Expert opinion on pharmacotherapy. 26, 3, p. 291-299 9 p.Research output: Contribution to journal › Review article* › Academic › peer-review
-
[18F]NaF PET/CT as a Marker for Fibrodysplasia Ossificans Progressiva: From Molecular Mechanisms to Clinical Applications in Bone Disorders
Zwama, J., Rosenberg, N. M., Verheij, V. A., Raijmakers, P. G. H. M., Yaqub, M., Botman, E., de Ruiter, R. D., Garrelfs, M. R., Bökenkamp, A., Micha, D., Schwarte, L. A., Teunissen, B. P., Lammertsma, A. A., Boellaard, R. & Eekhoff, E. M. W., 1 Oct 2024, In: Biomolecules. 14, 10, 1276.Research output: Contribution to journal › Review article* › Academic › peer-review
- All publications
